Clinical evaluation of red cell distribution width and contrast-induced acute kidney injury in percutaneous coronary interventions

Coronary Artery Disease

Volumn 26, Issue 4, 2015, Pages 283-285

  Nichols, Elizabeth L ^a   Brown, Jeremiah R ^a,b  

^a DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; CELLULAR DISTRIBUTION; CONTRAST INDUCED NEPHROPATHY; ERYTHROCYTE; HIGH RISK PATIENT; HUMAN; PATIENT CARE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ACUTE KIDNEY FAILURE; CHEMICALLY INDUCED; FEMALE; MALE; MEAN CORPUSCULAR VOLUME; MYOCARDIAL INFARCTION;

CONTRAST MEDIUM;

ACUTE KIDNEY INJURY; CONTRAST MEDIA; ERYTHROCYTE INDICES; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION;

EID: 84938537627     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0000000000000239     Document Type: Review

References (19)

1. Brown JR, Solomon RJ, Sarnak MJ, McCullough PA, Splaine ME, Davies L, et al. Reducing contrast-induced acute kidney injury using a regional multicenter quality improvement intervention. Circ Cardiovasc Qual Outcomes 2014; 7:693-700.
2. Tsai TT, Patel UD, Chang TI, Kennedy KF, Masoudi FA, Matheny ME, et al. Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry. JACC Cardiovasc Interv 2014; 7:1-9.
3. Koneth I, Weishaupt D, Bachli EB. Persistent nephrogram after administration of an isoosmolar contrast medium. Nephrol Dial Transplant 2004; 19:1654-1655.
4. Brown JR, McCullough PA. Contrast nephropathy and kidney injury. In: Thompson CA, editor. Textbook of cardiovascular intervention. London, UK: Springer-Verlag; 2014. pp. 53-63.
5. Kurtul A, Yarlioglues M, Murat SN, Demircelik MB, Acikgoz SK, Ergun G, et al. Red cell distribution width predicts contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome. Angiology 2014 [Epub ahead of print].
6. Sun XP, Chen WM, Sun ZJ, Ding XS, Gao XY, Liang SW, et al. Impact of red blood cell distribution width on long-term mortality in patients with ST-elevation myocardial infarction. Cardiology 2014; 128:343-348.
7. Yao HM, Sun TW, Zhang XJ, Shen DL, Du YY, Wan YD, et al. Red blood cell distribution width and long-term outcome in patients undergoing percutaneous coronary intervention in the drug-eluting stenting era: a two-year cohort study. PLoS One 2014; 9:e94887.
8. Dabbah S, Hammerman H, Markiewicz W, Aronson D. Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. Am J Cardiol 2010; 105:312-317.
9. Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 2008; 117:163-168.
10. Isik T, Kurt M, Ayhan E, Tanboga IH, Ergelen M, Uyarel H. The impact of admission red cell distribution width on the development of poor myocardial perfusion after primary percutaneous intervention. Atherosclerosis 2012; 224:143-149.
11. Akin F, Celik O, Altun I, Ayca B, Ozturk D, Satilmis S, et al. Relation of red cell distribution width to contrast-induced acute kidney injury in patients undergoing a primary percutaneous coronary intervention. Coron Artery Dis 2015; 26:289-295.
12. Cole J, Ertoy D, Lin H, Sutliff RL, Ezan E, Guyene TT, et al. Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice. J Clin Invest 2000; 106:1391-1398.
13. Gossmann J, Burkhardt R, Harder S, Lenz T, Sedlmeyer A, Klinkhardt U, et al. Angiotensin II infusion increases plasma erythropoietin levels via an angiotensin II type 1 receptor-dependent pathway. Kidney Int 2001; 60:83-86.
14. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004; 44:1393-1399.
15. Gurm HS, Seth M, Kooiman J, Share D. A novel tool for reliable and accurate prediction of renal complications in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol 2013; 61:2242-2248.
16. Mizuno A, Ohde S, Nishizaki Y, Komatsu Y, Niwa K. Additional value of the red blood cell distribution width to the Mehran risk score for predicting contrast-induced acute kidney injury in patients with ST-elevation acute myocardial infarction. J Cardiol [Epub ahead of print].
17. Brown JR, McCullough PA, Splaine ME, Davies L, Ross CS, Dauerman HL, et al. How do centres begin the process to prevent contrast-induced acute kidney injury: a report from a new regional collaborative. BMJ Qual Saf 2012; 21:54-62.
18. Brown JR, Robb JF, Block CA, Schoolwerth AC, Kaplan AV, O'Connor GT, et al. Does safe dosing of iodinated contrast prevent contrast-induced acute kidney injury? Circ Cardiovasc Interv 2010; 3:346-350.
19. Gurm HS, Dixon SR, Smith DE, Share D, Lalonde T, Greenbaum A, Moscucci M. BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) Registry. Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2011; 58:907-914.